Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.
The diagnosis of non-small cell lung carcinoma (NSCLC) at an early stage, as well as better prediction of outcome remains clinically challenging due to the lack of specific and robust non-invasive markers. The discovery of microRNAs (miRNAs), particularly those found in the bloodstream, has opened u...
Main Authors: | Céline Sanfiorenzo, Marius I Ilie, Amine Belaid, Fabrice Barlési, Jérôme Mouroux, Charles-Hugo Marquette, Patrick Brest, Paul Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3546982?pdf=render |
Similar Items
-
Long-Term Recurrence of Completely Resected NSCLC
by: Katsuhiro Masago, MD, PhD, et al.
Published: (2020-09-01) -
Circulating plasma microRNAs as diagnostic markers for NSCLC
by: Jinpao Hou
Published: (2016-11-01) -
Identification of Recurrence Related microRNAs in Hepatocellular Carcinoma after Surgical Resection
by: Zhen Yang, et al.
Published: (2013-01-01) -
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
by: Simon Heeke, et al.
Published: (2021-04-01) -
Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization
by: Radu Pirlog, et al.
Published: (2021-01-01)